Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank62
3Y CAGR-39.9%
5Y CAGR-23.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-39.9%/yr
Annual compound
5Y CAGR
-23.4%/yr
Recent deceleration
Percentile
P62
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 21.47% |
| 2023 | 39.94% |
| 2022 | 59.23% |
| 2021 | 98.73% |
| 2020 | -1156.02% |
| 2019 | 81.50% |
| 2018 | 99.64% |
| 2017 | -12476.44% |
| 2016 | 5.35% |
| 2015 | -23.63% |